117 related articles for article (PubMed ID: 28994286)
1. Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy.
Huang Z; Mou Y; Xu X; Zhao D; Lai Y; Xu Y; Chen C; Li P; Peng S; Tian J; Zhang Y
J Med Chem; 2017 Nov; 60(21):8847-8857. PubMed ID: 28994286
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs.
Liu L; Pan X; Xie F; Xu X; Xiao D; Xiao J; Zhou X
Bioorg Chem; 2022 Jul; 124():105831. PubMed ID: 35512420
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
Borella R; Forti L; Gibellini L; De Gaetano A; De Biasi S; Nasi M; Cossarizza A; Pinti M
Molecules; 2019 Nov; 24(22):. PubMed ID: 31766211
[TBL] [Abstract][Full Text] [Related]
4. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
[TBL] [Abstract][Full Text] [Related]
5. Location, Orientation and Aggregation of Bardoxolone-ME, CDDO-ME, in a Complex Phospholipid Bilayer Membrane.
Galiano V; Encinar JA; Villalaín J
J Membr Biol; 2020 Apr; 253(2):115-128. PubMed ID: 31965219
[TBL] [Abstract][Full Text] [Related]
6. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.
Nagaraj S; Youn JI; Weber H; Iclozan C; Lu L; Cotter MJ; Meyer C; Becerra CR; Fishman M; Antonia S; Sporn MB; Liby KT; Rawal B; Lee JH; Gabrilovich DI
Clin Cancer Res; 2010 Mar; 16(6):1812-23. PubMed ID: 20215551
[TBL] [Abstract][Full Text] [Related]
8. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
[TBL] [Abstract][Full Text] [Related]
9. Efficient and scalable synthesis of bardoxolone methyl (cddo-methyl ester).
Fu L; Gribble GW
Org Lett; 2013 Apr; 15(7):1622-5. PubMed ID: 23530743
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new azoreductase driven prodrug from bardoxolone methyl and 5-aminosalicylate for the treatment of colitis in mice.
Qiao X; Gong Y; Mou Y; Zhang YH; Huang ZJ; Wen XD
Chin J Nat Med; 2021 Jul; 19(7):545-550. PubMed ID: 34247779
[TBL] [Abstract][Full Text] [Related]
11. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells.
Qin D; Wang W; Lei H; Luo H; Cai H; Tang C; Wu Y; Wang Y; Jin J; Xiao W; Wang T; Ma C; Xu H; Zhang J; Gao F; Wu YL
Oncotarget; 2016 Nov; 7(47):77096-77109. PubMed ID: 27780924
[TBL] [Abstract][Full Text] [Related]
12. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
[TBL] [Abstract][Full Text] [Related]
13. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.
Atilano-Roque A; Aleksunes LM; Joy MS
Toxicol Lett; 2016 Sep; 259():52-59. PubMed ID: 27480280
[TBL] [Abstract][Full Text] [Related]
14. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
15. Synthetic oleanane triterpenoids: magic bullets or not?
Abboud HE
Kidney Int; 2013 May; 83(5):785-7. PubMed ID: 23633050
[TBL] [Abstract][Full Text] [Related]
16. Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me).
Yue P; Zhou Z; Khuri FR; Sun SY
Cancer Biol Ther; 2006 May; 5(5):492-7. PubMed ID: 16582599
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells.
Qin DJ; Tang CX; Yang L; Lei H; Wei W; Wang YY; Ma CM; Gao FH; Xu HZ; Wu YL
PLoS One; 2015; 10(7):e0132337. PubMed ID: 26134508
[TBL] [Abstract][Full Text] [Related]
18. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.
Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB
Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868
[TBL] [Abstract][Full Text] [Related]
19. The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent.
Vannini N; Lorusso G; Cammarota R; Barberis M; Noonan DM; Sporn MB; Albini A
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3139-46. PubMed ID: 18065492
[TBL] [Abstract][Full Text] [Related]
20. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.
Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY
Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
